Form 4 for RMD ResMed|
Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-18 · accession 0000943819-21-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-22 | 2021-11-18 | RMD | FARRELL PETER C | Dir | A - Grant | $0.00 | +478 | 192.1K | +0.2% | $0 |
| D | 2021-11-22 | 2021-11-18 | RMD | FARRELL PETER C | Dir | A - Grant | $0.00 | +1,695 | 1,695 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2021-11-18 | A | A | 478 | $0.00 | 192,102 | D | — | — | (F1) Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2022, or the annual shareholder's meeting in the year following the grant date. |
| 2 | Derivative | ResMed Common Stock Options | 2021-11-18 | A | A | 1,695 | $0.00 | 1,695 | D | $263.16 · 2022-11-11 to 2028-11-18 | 1,695 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest on the earlier of (i) the first November 11 following the Grant Date, or (ii) the date of the first (1st) annual meeting of stockholders of the Company following the Grant Date. |